XML 70 R43.htm IDEA: XBRL DOCUMENT v3.24.1
Equity (Tables)
12 Months Ended
Dec. 31, 2023
Schedule of status of the restricted stock grants

The Year Ended December 31,

 

2023

2022

 

    

    

Weighted 

    

    

Weighted 

 

Average

Average 

 

Grant Date 

Grant Date 

 

Number of 

Fair Value 

Number of 

Fair Value 

 

Restricted Stock Grants

Shares

 Per Share

Shares

Per Share

 

Outstanding at beginning of period

19,800

$

10.95

11,733

$

15.26

Granted during the period

 

 

 

22,000

 

9.41

Restrictions lifted during the period

 

(12,933)

 

11.97

 

(13,933)

 

12.14

Forfeited during the period

 

(1,067)

 

9.75

 

 

Outstanding at end of period

5,800

$

8.89

19,800

$

10.95

Schedule of status of the stock option grants issued under the Equity Plan

The Year Ended December 31,

 

2023

2022

 

    

    

Weighted 

    

    

Weighted 

 

Average 

Average 

 

Grant Date 

Grant Date 

 

Number of 

Fair Value 

Number of 

Fair Value 

Restricted Stock Units

Shares

Per Share

Shares

Per Share

 

Outstanding at beginning of period

232,409

$

15.06

164,409

$

17.20

Granted during the period

 

40,000

 

1.62

 

68,000

 

9.90

Restrictions lifted during the period

 

 

 

 

Forfeited during the period

 

 

 

 

Outstanding at end of period

272,409

$

13.09

 

232,409

$

15.06

Summary of the status of the Company's common stock warrants

Weighted 

Number of

Average

Underlying

Exercise Price

Common Stock Warrants 

Shares

Per Share

Outstanding at December 31, 2021

512,155

$

8.62

Exercised during period

July 2019 Series B Warrants

(120,000)

8.75

Outstanding at December 31, 2022

392,155

$

8.58

Granted during period

 

 

June 2023 Pre-Funded Warrants

637,587

0.0001

June 2023 Warrants

1,427,587

1.90

November 2023 Series A Warrants

6,000,000

0.70

November 2023 Series B Warrants

3,000,000

0.70

November 2023 Pre-Funded Warrants

1,287,512

0.0001

Exercised during period

June 2023 Pre-Funded Warrants

(637,587)

0.0001

November 2023 Pre-Funded Warrants

(798,940)

0.0001

Outstanding at December 31, 2023

11,308,314

$

1.09

April 2020  
Summary of the status of the Company's common stock warrants

Number of

Exercise

Common Stock Warrants

Warrants

Price

Expiration Date

July 2019 Series A Warrants

    

338,155

    

$

8.75

    

January 17, 2025

July 2019 Series B Warrants

$

8.75

May 6, 2022

April 2020 Series A Warrants

44,000

$

7.50

October 22, 2025

April 2020 Series B Warrants

10,000

$

7.50

October 22, 2025

June 2023 Pre-Funded Warrants

$

0.0001

December 26, 2028

June 2023 Warrants

1,427,587

$

1.90

December 26, 2028

November 2023 Series A Warrants

6,000,000

$

0.70

November 6, 2023

November 2023 Series B Warrants

3,000,000

$

0.70

November 6, 2023

November 2023 Pre-Funded Warrants

488,572

$

0.0001

Upon exercise

11,308,314